Results 71 to 80 of about 3,726 (164)
Epidemiology of human African trypanosomiasis
Jose R Franco,1 Pere P Simarro,1 Abdoulaye Diarra,2 Jean G Jannin1 1World Health Organization, Control of Neglected Tropical Diseases, Innovative and Intensified Disease Management, Geneva, Switzerland; 2World Health Organization, Inter Country Support ...
Franco JR +3 more
doaj
SummaryThree groups of stocks of Trypanosoma brucei ssp, defined by the criteria of host, human serum resistance and place of isolation as T. b. gambiense, T. b. brucei (Nigeria) and T. b. brucei/rhodesiense (non-gambiense, Uganda) were screened for electrophoretic variation at 20 enzyme loci.
A, Tait, E A, Babiker, D, Le Ray
openaire +2 more sources
African Trypanosomiasis Gambiense, Italy
African trypanosomiasis caused by Trypanosoma brucei gambiense has not been reported in Italy. We report 2 cases diagnosed in the summer of 2004. Theses cases suggest an increased risk for expatriates working in trypanosomiasis-endemic countries.
Zeno Bisoffi +7 more
doaj +1 more source
A CASE OF HUMAN AFRICAN TRYPANOSOMIASIS during UNITED NATION MISSION IN LIBERIA
Human African trypanosomiasis (HAT) or sleeping sickness is caused by Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense, and is endemic/epidemic in many countries of Africa1.
Muhammad Ayub +3 more
doaj +2 more sources
Trypanosoma brucei gambiense causes Gambian trypanosomosis, a disease ravaging affected rural parts of Sub-Saharan Africa. We screened 1200 human blood samples for T. b.
Karshima Solomon Ngutor +2 more
doaj +1 more source
Human African Trypanosomiasis Transmission, Kinshasa, Democratic Republic of Congo
To investigate the epidemiology of human African trypanosomiasis (sleeping sickness) in Kinshasa, Democratic Republic of Congo, 2 entomologic surveys were conducted in 2005.
Gustave Simo +7 more
doaj +1 more source
Strategies for Trypanosoma brucei gambiense elimination [PDF]
Pandey, Abhishek, Galvani, Alison
openaire +2 more sources
Background In a mammalian host, the cell surface of African trypanosomes is protected by a monolayer of a single variant surface glycoprotein (VSG). The VSG is central to antigenic variation; one VSG gene is expressed at any one time and there is a low ...
Sharma Reuben +6 more
doaj +1 more source
Immunoinformatic design of a putative multi-epitope vaccine candidate against Trypanosoma brucei gambiense. [PDF]
Danazumi AU +5 more
europepmc +1 more source
Gambiense trypanosomiasis is considered an anthroponotic disease. Consequently, control programs are generally aimed at stopping transmission of Trypanosoma brucei gambiense (T. b. gambiense) by detecting and treating human cases.
Carlos eCordon-Obras +11 more
doaj +1 more source

